The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection.

/in /by

Koh AY.  The microbiome in hematopoietic stem cell transplant recipients and cancer patients: Opportunities for clinical advances that reduce infection. PLoS Pathogens 2017 Jun 29; 13(6):e1006342. PMID: 28662165.   There is no Abstract link.  Full Text

You might also like
Murine models of Candida gastrointestinal colonization and dissemination.
Collaboration between macrophages and vaccine-induced CD4+ T cells confers protection against lethal Pseudomonas aeruginosa pneumonia during neutropenia.
The complexities of bacterial-fungal interactions in the mammalian gastrointestinal tract.
Identifying host immune effectors critical for protection against Candida albicans infections.
Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients.
Antibiotic-induced depletion of anti-inflammatory Clostridia is associated with the development of GVHD in pediatric stem cell transplant patients.
Candida albicans inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.
Severe gut microbiota dysbiosis is associated with poor growth in patients with short bowel syndrome.